Insulin resistance in psoriasis: beyond comorbidity?
Clicks: 8
ID: 327961
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
2.1
/100
8 views
7 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #282 of 352 articles by views in the british journal of dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 352 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Insulin resistance is increasingly recognised as being closely linked to psoriasis severity and treatment response, rather than simply representing an associated metabolic comorbidity. Emerging evidence for GLP-1 receptor agonists further supports the potential for targeting metabolic dysfunction as part of psoriasis management.
| Reference Key |
openalex_W7208816084
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Emma Carroll, Maria Visan, Maeve Herlihy, Anne‐Marie Tobin, Rosalind Hughes, Brian Kirby |
| Journal | the british journal of dermatology |
| Year | 2026 |
| DOI |
10.1093/bjd/ljag383
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.